SUBSCRIBE
SUBSCRIBE
News   Drug Development

Pfizer Inc., Roche Holding AG (JOBS), Bayer AG, and Wyeth Cancer Drugs Rejected by U.K. Agency on Cost

August 8, 2008 | 
1 min read
Aug. 7 (Bloomberg) -- Pfizer Inc., Roche Holding AG, Bayer AG and Wyeth's cancer treatments were rejected for use in advanced kidney cancer patients in a preliminary recommendation by a U.K. panel that studies the cost-effectiveness of medicines.
Clinical research Postmarket research
Pfizer
MORE ON THIS TOPIC
The factor that changes everything. A critical break. A sudden change in plans. A threat and a danger. Recover from the blow and get back on course. Severe stress. Withstand the blow.
Obesity
Zealand Freezes Mid-Stage Obesity Asset to Focus on More Differentiated Drugs
November 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Collage image sketch of tired girl sleeping home nightmare monster in room isolated on drawing background.
Neuroscience
Alkermes Pushes Narcolepsy Program to Phase III With ‘Highly Competitive’ Mid-Stage Data
November 13, 2025
 · 
2 min read
 · 
Tristan Manalac
too many different pill of various blisters with different pills Medicines storage at home concept Medication storing. A pile of medicine in blister packs. Pharmaceutical blister packs.
Drug Development
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
November 12, 2025
 · 
5 min read
 · 
Jennifer Smith-Parker
3d fatty liver disease isolated on pink background. 3d illustration render
MASH
Altimmune Poised for $1B+ Opportunity as MASH Drug Aces Phase IIb
November 12, 2025
 · 
2 min read
 · 
Tristan Manalac